Loading data for UPB — first visit, this takes a few seconds.

アラート

Upstream Bio Inc. (UPB)

NasdaqGS: UPB · リアルタイム株価 · USD

6.97

+0.12 (1.75%)

終値時点： Aug 21, 2026, 8:00 PM

6.84

-1.87%

時間外: 7:30 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

1.75% (1D)

データがありません

買気配	4.94
時価総額	381.75M
売上高（TTM）	3.16M
純利益（TTM）	-156.5M
	n/a
	-2.88
	n/a
	-2.38
PBR（TTM）	1.25
PSR（TTM）	120.88
決算発表日	Nov 4, 2026

売気配	8.85
出来高	434,117
平均出来高（20日）	607,950
始値	6.91
前日終値	6.85
当日レンジ	6.85 - 7.01
52週レンジ	5.85 - 33.68
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

UPBについて

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headqu...

[続きを読む]

業種 Biotechnology

セクター Healthcare

IPO日 Oct 11, 2024

従業員数 75

上場取引所 NasdaqGS

ティッカー UPB

ウェブサイト https://upstreambio.com

企業情報の全文

業績

2025年のUpstream Bioの売上高は2.85Mで、前年の2.37Mから20.42%の増加でした。利益は-143.44Mで、128.39%の増加でした。

財務諸表

決算サプライズ

Upstream BioはAug 11, 2026に四半期決算を発表しました：

売上高は $1.03M で、予想を下回りました $0, うち 82.69% の前年比増加にあたります.
EPSは -0.73 で、予想を上回りました 0.03, うち 1.35% の前年比増加にあたります.

次回決算発表

Upstream Bio Inc.の決算発表予定日は Nov 4, 2026, 寄り付き前の予定です。
アナリストの売上高予想は ... アップグレード

ニュース

1週間前 · Zacks

Upstream Bio, Inc. (UPB) Reports Q2 Loss, Tops Revenue Estimates

Upstream Bio, Inc. (UPB) delivered earnings and revenue surprises of +6.41% and +15.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

1か月前 · Zacks

Upstream Bio, Inc. (UPB) Upgraded to Buy: What Does It Mean for the Stock?

Upstream Bio, Inc. (UPB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1か月前 · Insider Monkey

Is Upstream Bio, Inc. (UPB) a Rising Biotech Opportunity After New Analyst Coverage?

We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Upstream Bio, Inc. (NASDAQ:UPB) is one of the most promising stocks on our list. TheFly reported ...

2か月前 · Insider Monkey

Is Upstream Bio, Inc. (UPB) the Best Low Priced Stocks to Get Rich in 2026?

Upstream Bio, Inc. (NASDAQ:UPB) is among the best low priced stocks to get rich in 2026. On June 12, JPMorgan significantly trimmed the price target on Upstream Bio, Inc. (NASDAQ:UPB) to $8 from $35, ...

3か月前 · Zacks

Upstream Bio, Inc. (UPB) Reports Q1 Loss, Beats Revenue Estimates

Upstream Bio, Inc. (UPB) delivered earnings and revenue surprises of +5.96% and +102.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

2ページ中1ページ

Upstream Bio Inc. (UPB)